Johns Hopkins Hospital Study Shows Hydrogen Peroxide Vapor Technology Reduces Patient Risk

Johns Hopkins Hospital Study Shows Hydrogen Peroxide Vapor Technology Reduces Patient Risk of Superbug Infection

Findings indicate Bioquell system should be used in high-risk settings to maximize patient safety

Horsham, PA – January 2, 2013 – A new study conducted by infection control experts at Johns Hopkins Hospital demonstrates that patients admitted to hospital rooms decontaminated using Bioquell hydrogen peroxide vapor technology, rather than standard cleaning protocols, were significantly less likely to acquire multidrug-resistant organisms (MDROs), or so-called hospital superbugs. The study is published in this month’s issue of Clinical Infectious Diseases.

The Bioquell system consists of automated devices that disperse an Environmental Protection Agency (EPA)-registered sterilant into the air and onto surfaces and then convert the sterilant to a harmless state.

Previous research has shown that being admitted to a hospital room where the previous patient was infected or colonized with an MDRO, such as Clostridium difficile, methicillin-resistantStaphylococcus aureus (MRSA)or vancomycin-resistant enterococci (VRE), increases the subsequent patient’s chance of acquisition. The objective of this study was to determine whether the Bioquell system, which has been shown to eliminate surface contamination in patient rooms, could negate this risk. Researchers found that patients admitted to rooms decontaminated using the automated technology were 64% less likely to acquire MDROs compared to patients admitted to rooms disinfected using conventional methods, such as mopping with bleaching agents.

“The findings indicate that Bioquell hydrogen peroxide vapor disinfection should be implemented in high-risk environments to maximize patient safety,” said James Salkeld, head of healthcare at Bioquell. “Before this research, hospitals had legitimately asked whether they could afford the 90 minutes it takes to perform a Bioquell cycle. With the study showing acquisition being reduced by over 50% in patients admitted to decontaminated rooms, this begs a new question: can they afford not to?”

– See more at: 

http://www.bioquell.ie/news/johns-hopkins-study-shows-HPV-technology-reduces-patient-risk/

Leave a Reply

avatar
  Subscribe  
Notify of